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Chapter 1
Cloning Rhodopsin: An Introduction

1.1 What are GPCRs?
Examining the role and function of G-protein coupled receptors
(GPCRs) within the human body is critical. GPCRs are transmembrane
proteins (Trabanino et al., 2004) and encompass an estimated 950 genes
within the human genome (Fredriksson and Schioth, 2005; Mirzadegan et al.,
2003; Takeda et al., 2002). Their importance rests upon their ability to
transduce extracellular signals, detect and mediate hormonal and sensory
stimuli (Heideman and Bourne, 1990), and participate in electron transfer and
ion transport (Trabanino et al., 2004).

1.2 Mechanism of action
GPCRs consist of 7 transmembrane helices; hence, inclusion within
the 7-transmembrane receptor family (Peirce et al., 2002; Leftkowitz, 2004).
They possess an extracellular N-terminus, 3 extracellular loops, 3 intracellular
loops, and an intracellular C-terminus (Salom et al., 2005). The activation of
a GPCR occurs from the binding of an extracellular ligand (receptor-specific)
to its transmembrane domain. Immediately after ligand binding, the GPCR
undergoes a conformational change that allows for the binding of a G-protein
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to the intracellular domain of the GPCR, causing the activation of the Gprotein and the internal relaying of the extracellular signal. However, various
subclasses of GPCRs are highly similar in structure and are affected not only
by the agonists and antagonists within their individual subclass, but by the
agonists and antagonists of other subclasses as well. This most often results in
unwanted side effects. Drug design targeting only one GPCR is frequently
encountered with difficulty and frequently results in adverse side effects
(Trabanino et al., 2004). Yet, of the presently available therapeutic drugs,
approximately 40% of them target GPCRs (Muller, 2000; Sautel et al., 2000).
Properly functioning GPCRs are critical components of normal body
function and sound health. Minor mutations in GPCR structures potentially
result in diseases such as diabetes and hypertension (mutated in the Glucagon
receptor), dwarfism (deficient Growth hormone releasing hormone), obesity
(malfunctioning ß-3-Adrenoceptor), and retinitis pigmentosa (mutated
Rhodopsin) (Wilson, et al., 1998). Other manifested conditions resulting from
deficient GPCRs include: allergies, anxiety, asthma, congestive heart failure,
migraines, Parkinson’s, and ulcers (Wilson and Bergsma, 2000).
Fully operative GPCRs are therefore essential in proper conduction of
many biological processes and malfunctioning GPCRs are potentially
detrimental. Pharmaceutical companies are diligent in their attempts to design
therapeutic agents and improve existing ones to mimic the natural agonists
and antagonists that are specific in their target of GPCRs. These companies
would be more successful in their efforts if the identity and structures of more
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GPCRs were known. However, much of what is currently known about
GPCR structure was based on X-ray crystallographic measurements of
rhodopsin. This was the only GPCR with a known structure until the recent
determination of the crystal structure of the human ß2 adrenergic G-protein
coupled receptor (Rasmussen et al., 2007).

1.3 Why study rhodopsin?
Rhodopsin is the prototype for GPCRs and therefore widely studied
(Menon et al., 2001; Okada et al., 2001; Shichide and Yamashita, 2003). The
extensive study conducted on rhodopsin is based on its ability to be highly
expressed in eyes, availability and access for electrophysiological
manipulations, rapid, quantifiable conversion of its chromophore1 ligand
between inverse states, and its vital role in vision (Ebrey and Koutalos, 2001;
Hargrave, 2001; Okada et al., 2001; Okada and Palczewski, 2001; Filipek et
al., 2003(b)). The crystallized structure of rhodopsin is invaluable to current
information collected on GPCRs. Earliest crystallized structures detailed the
helical arrangements, interhelical interactions, cytoplasmic helix 8,
chromophore binding site, and extracellular ligand binding interactions in
other types of GPCRs (Palczewski et al., 2000). The advent of high resolution
diffracted rhodopsin crystals provided further in-depth analysis on the
cytoplasmic loops and water molecule interactions of the chromophore (Li et
al., 2004; Okada et al., 2004).
1

A chromophore is a pigmented molecule that exhibits color due to its absorption of specific
wavelengths of light. The chromophore in rhodopsin consists of the covalent interactions of
the protein opsin and retinal.
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1.4 What is rhodopsin?
Rhodopsin, an extremely light-sensitive membrane protein, is
classifiable as photosensitive (Salom et al., 2005). Rhodopsin is composed of
a retinal-protein complex, where retinal is covalently bonded to opsin
(Wolken, 1995).

Formation of the covalent bond occurs when an aldehyde

group within retinal bonds to a lysine residue (ε-amino acid) in opsin, creating
a protonated Schiff base. As rhodopsin absorbs a photon of light, 11-cis
retinal is photoisomerized to the all-trans form, generating the active form.

Figure-1.1 Structures of 11-cis and all-trans retinal.

Further, rhodopsin and retinal are universally found in all animal
retinas. Even unicellular organisms, such as algae, halophilic bacteria, and
protozoa utilize rhodopsins which function as light detectors for phototactic
movement rather than visual excitation as in animals (Wolken, 1995).

5
In its inactive form rhodopsin exhibits red to purple hues and absorbs
light at 500 nm. Contrastingly, when it is activated by light, it bleaches to a
white color and absorbs light at 370 nm (Wolken, 1995). Photobleaching,
fortunately, is avoidable by conducting rhodopsin experiments in the dark
(Salom et al., 2005).
In previous procedures, rhodopsin has been extracted from fresh
bovine retinas (Salom et al., 2005; Tachibanaki, et al., 1998). By expressing
bovine rhodopsin in Escherichia coli (E. coli) (or other unicellular organisms)
through cloning, extraction of the protein is cheaper, less complex, and
advantageous.

1.5 Importance of cloning
The fields of biology, medicine, and biotechnology have been
revolutionized through the employment of recombinant DNA technology with
gene cloning as its central component. As a vital tool in biology, gene cloning
conveniently isolates a desired gene, further allowing its assessment. Gene
cloning has also provided a way for mammalian proteins and genes to be
inserted and produced in bacterial cells. Cloned genes are frequently
manipulated and made to exist and function in an organism in which it is not
naturally found (Brown, 1990). Nevertheless, gene cloning has significantly
impacted biological research and biotechnology, and the information obtained
from the structure and function of a cloned gene is very valuable (Brown,
1990).
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1.6 What is gene cloning?
The process of gene cloning can best be conveyed in a series of basic
steps. In order for the cloning process to begin, two essential components are
needed, purified DNA from the cloning vehicle and purified DNA from the
prospective gene to be cloned.
1. The prospective gene to be cloned is inserted into a vector, or a
circular piece of DNA. The cloned gene plus the vector is a product
called recombinant DNA.
2. The vector’s primary function is to transport the gene to be cloned into
a host cell, which is usually a bacterium. So in essence, the vector acts
as a vehicle. In the experiment, E.coli cells are used.
3. When in the host cell, the vector multiplies and produces identical
copies of itself along with the inserted gene.
4. As the host cell divides, copies of the vector containing the cloned
gene are passed on to its progeny.
5. The host cell continuously divides until it forms a colony – a collection
of cells, identical to the host, that all contain the recombinant DNA
molecule.
The single most important aspect of the gene cloning process is the
method by which a recombinant DNA molecule is transported and integrated
into the host cell. In order for a vector to perform its function as a vehicle of
cloning, it must possess two key features: it must be readily and easily able to
enter the host cell, and it must be self-replicating or able to produce multiple
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copies of itself. Fortunately, two types of DNA, plasmids and bacteriophages,
are natural cloning vehicles that exist to facilitate the cloning process.
Plasmids are small, circular extrachromosomal pieces of DNA that can
replicate independently of the host cell’s chromosome. Bacteriophages, on
the other hand, are viral chromosomes that invade and infect bacteria.
(Brown, 1990).

The Cloning Process

Figure-1.2 Summarizes the gene cloning process. Figure is adopted from
(Brown, 1990).
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1.7 Problems with cloning
Cloning a foreign gene into E.coli, specifically a mammalian protein,
is not without complications. Difficulties often ensue with large-scale
expression of protein from these cloned genes.

Problems found on the

transcription and translation levels, whether in between or after both stages,
are at the cellular level.
1. One common problem arising during the transcription phase is the
presence of a sequence within the foreign gene that performs as a
termination sequence within E. coli. The aforementioned sequence is
innocuous within the native host cell; nevertheless, it causes an
untimely loss of gene expression in E.coli.
2. Between transcription and translation one major problem is the
presence of introns in the non-native gene. The removal of introns
must occur before the non-native gene can be cloned into E.coli
because the bacteria are incapable of excising the introns.
3. Problems surfacing at the translation phase are complex and surround
the use of codons. Even though the same genetic code is employed by
almost all living creatures, some organisms exhibit a preference for
select codons. Transfer RNAs (tRNAs) preference for the use of
certain codons in E.coli may cause an over abundance of that specific
tRNA and relatively little amounts of various types of tRNAs for
decoding the infrequent codons. If the cloned gene has a relatively
large amount of unfavorable codons (in relation to E.coli) then the
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translation phase in E.coli may be thwarted by low levels of the
infrequent tRNAs.
4. Immediately after translation, the cloned gene product may be
subjected to rapid degradation. The use of a mutant E.coli strain
(which lacks many proteases2) smartly avoids the degradation of the
cloned gene product. An additional problem that may surface after the
completion of translation involves processing. In most organisms,
sugar groups are added to proteins (specifically those from animals)
after translation, and addition of these functional groups aids normal
protein functioning. E.coli, however, will not add the sugar groups to
the recombinant proteins, which results in the formation of a nonfunctional protein.
5. At the cellular level, a cloned mammalian gene may be harmful to the
host cell. Even when not toxic to the bacterial cells, fast expression of
the recombinant protein is thought to cause delayed growth and
cellular instability, especially when compared to an E.coli cell lacking
the recombinant gene (Brown, 1990).

1.8 Summary
Cloning a mammalian gene into bacterial cells is a huge undertaking
as uncertainties lie in the ability of the cloned gene to be expressed. Despite
problems associated with mammalian gene cloning, an optimistic outlook

2

Proteases are enzymes that solely function to degrade proteins into their constituent
peptides.
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should still be employed because not all recombinant genes (when expressed
in E.coli) fail to produce insufficient amounts of recombinant proteins. This is
reason enough to believe the cloning of bovine rhodopsin into E.coli will
work.
In the current experiment, the bovine rhodopsin protein, a mammalian
gene, has been cloned into a non-native E.coli strain UT5600. The main goal
is to assess the capability of the bovine rhodopsin gene, a GPCR, to be
expressed as a functional protein in bacterial cells.
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Chapter 2
Methodology

Before the cloning process can ensue, two essential components are
needed, the cloning vehicle and purified DNA from the prospective gene to be
cloned. The pBAD TOPO vector was used as a cloning vehicle in the
experiment, and the prospective gene to be cloned was the Bovine rhodopsin
gene.

2.1 Cloning Vector
The pBAD TOPO TA Expression kit purchased from Invitrogen was
used to conduct the cloning process. The PBAD TOPO plasmid contains
special properties making it a suitable, efficient cloning vehicle. These two
properties are: 1). A topoisomerase that is already bound to the pBAD TOPO
vector and 2). A solitary 3’-thymidine (T) overhang on both ends of the
vector. (Thymidine or deoxythymidine is one of the 4 bases found in DNA
that pairs with deoxyadenosine (A).)
The 3’-(T) overhang’s principal purpose is to bind to the PCR product
(the prospective gene to be cloned) which contains (A) overhangs, thus
constituting the self-ligating properties of the pBAD TOPO vector.
Consequently, the use of a ligase to bind the PCR product to the pBAD TOPO
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vector is unnecessary. A Taq polymerase (which will be subsequently
discussed and also supplied by the pBAD TOPO TA Expression kit) is
responsible for adding a single (A) to either ends of the PCR product.
Functions of the Vaccinia Topoisomerase 1
Bound to the pBAD TOPO vector is a topoisomerase 13 derived from
the Vaccinia virus. The Vaccinia topoisomerase 1 is 314 amino acids in
length (Shuman and Moss, 1987), and its primary function is to bind to duplex
DNA and cleave the phosphodiester backbone of one strand (Shuman, 1994).
The extreme sequence specificity of Vaccinia topoisomerase 1 allows it to
recognize and cleave DNA at the 5’ CCCTT in the scissile strand (Shuman
and Prescott, 1990; Shuman and Prescott, 1991a. 1991b). Also, it is an
especially useful tool because it operates as a site-specific restriction
endonuclease, which selectively cleaves DNA at highly specific sites;
however, it also religates DNA strands with great proficiency. Restriction
endonucleases have been traditionally used to cleave DNA at specific sites to
produce linear DNA that would then be religated at their ends with DNA
ligase. With the advent of Vaccinia topoisomerase 1, what was once a twostep method for inserting a non-native gene into a vector is now one single
step. Furthermore, this single-step method is used in vitro to label DNA ends
and to clone DNA molecules (Shuman, S., 1994). Moreover, Invitrogen has
utilized the specificity of and the discriminatory power in end ligation of
Vaccinia topoisomerase 1 and incorporated it into the pBAD TOPO® vector.
3

A topoisomerase is an enzyme that functions to alter and manipulate DNA structure whether
by purposefully introducing supercoils or contrastingly, relieving supercoils in the
conformation of DNA (Brown, 1990).
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2.2 Properties of PCR
An exciting moment in scientific history occurred during 1985-1986,
when researchers at Cetus Corporation, USA, established a revolutionary in
vitro technique for amplifying DNA fragments. This process is called the
polymerase chain reaction, but is more commonly referred to as PCR
(Chawla, 2000).
PCR is especially useful because it quickly and easily amplifies a
minute amount of DNA. Amplification of a DNA sequence in PCR occurs in
3 main steps.
1. The double stranded DNA template is heated to 94 degrees Celsius to
achieve denaturation.
2. Synthetic DNA primers anneal to the target sequences on either side of
the DNA region to be amplified. This process is carried out at 35-65
degrees Celsius.
3. DNA synthesis of the targeted region occurs from the 3’ hydroxyl end
of each DNA primer by Taq polymerase. This step occurs in repetitive
cycles, and the primer extension products of antecedent cycles serve as
a new template for subsequent cycles. Hence, the number of targeted
DNA copies may double each cycle, hence, the term amplification.
It should be noted that a minute amount of Taq polymerase, approximately
1unit (but no more than 2 units) is need to carry out PCR, as an excess may
cause the amplification of non-target sequences (Chawla, 2000).
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Comprehending the central components of PCR is vital for further
understanding its complexity. PCR is best conveyed when broken into its
central components. Three significant components of PCR include:
1. Known nucleotide sequences, at both ends of the selected DNA region
to be amplified, allow for DNA primers (both forward and reverse) to
anneal to the targeted DNA molecule.
2. The sole function of DNA primers is to demarcate the region of DNA
that will be enzymatically amplified. DNA primers are also known as
oligonucleotides, which are short, synthesized sequences of DNA or
RNA that are typically 25 nucleotides or fewer in length.
3. Taq polymerase, or DNA polymerase 1 from Thermus acquaticus4, is
necessary for the amplification of the selected DNA region. Taq
polymerase, a thermostable enzyme discovered by Kary Mullis, ably
endures denaturation in environments up to 94 degrees Celsius. The
Klenow fragment, obtained from DNA polymerase 1 in E. coli, was
initially used to execute PCR. While functional and structural
properties of Taq polymerase resembled those of DNA polymerase 1
of E. coli (Joyce and Grindley, 1983), DNA polymerase 1 was illsuited for the denaturation cycle in PCR.
Other important components included in PCR are the amplification buffer,
which typically contains KCl, Tris-chloride, and MgCl2, and
deoxyribonucleoside triphosphates (DNTPs) at a concentration of 200 µM
(Chawla, 2000).
4

Thermus acquaticus is a bacterium native to hot springs.
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Additional Functions of Taq Polymerase
Taq polymerase functions to replace nucleosides in DNA repair and
also remove RNA primers during the processing of Okazaki fragments
(Kernberg and Baker, 1992). In nucleotide editing reactions, two prominent
domains allow Taq polymerase to exhibit dual functions. The N-terminal
domain has 5’-nuclease activity which cleaves RNA primers or defective
DNA strands, and the C-terminal domain has DNA polymerase activity which
synthesizes new DNA strands (Ho, D. et al., 2004). One limitation to the
function of Taq polymerase is its lack of 3’ to 5’ exonuclease activity. It is
thereby unable to proofread and remove mismatched bases making it slightly
less efficient than other naturally existing polymerases. Fortunately, other
thermostable enzymes with proofreading capabilities have been isolated
(Chawla, 2000). In summary, the nuclease and polymerase activity of Taq
polymerase has been utilized by Invitrogen to allow the non-template transfer
of a solitary (A) to each 3’ end of the PCR product.

2.3 PCR Product
Complementary DNA (cDNA) is a single-stranded DNA transcript
synthesized from an mRNA template, and its synthesis is catalyzed by reverse
transcriptase. Once the cDNA transcript is produced, the second strand of
cDNA is made from DNA polymerase 1. Formation of the double-stranded
cDNA may then be fused into a vector and cloned (Brown, 1990).
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Genomic DNA of cells containing cloned cDNA of bovine rhodopsin
was used as a PCR template in my experiment. The PCR product, cDNA of
bovine rhodopsin, was contributed by Jeremy Nathans, et al. (1989). In
addition, Nathans et al. sub-cloned the cDNA encoding bovine rhodopsin and
the protein was expressed in human cells. When treated in vitro with 11-cis
retinal, these cells containing the cloned cDNA of bovine rhodopsin generated
a red pigment with an absorbance identical to the original bovine rhodopsin
(Nathans, J. et al., 1989).
I used PCR to amplify the cDNA of bovine rhodopsin and to add new
restriction enzyme sites using the template provided by Nathans. The PCR
product was then treated with Taq polymerase provided by the Invitrogen
pBAD TOPO® cloning system, in order to add (A) overhangs required to
ligate the PCR product to the 3’ (T) overhangs within the pBAD TOPO
vector.
As previously mentioned, DNA primers are needed to mark or isolate
the region of DNA that will be enzymatically amplified. The following DNA
primers, as shown in Figure-2.1, were designed and purchased for the PCR
product. The forward primer begins with an in-frame stop codon (TAG) and
is subsequently followed by the ribosome binding site (AGGA) which
functions as a translation re-initiation sequence. The ATG start codon of the
bovine rhodopsin cDNA follows the ribosome binding site 7 nucleotides later.
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Figure-2.1 Forward and Reverse DNA primers used in the PCR amplification of the cDNA
encoding bovine rhodopsin. DNA primers mark the region where the bovine rhodopsin gene
will be amplified during PCR.

This construction of the rhodopsin polypeptide sequence permits
expression from the araBAD promoter without the enterokinase leader
sequence. Devoid of the protective space provided by the 6 nucleotides
(between the ribosome binding site (AGGA) and the start codon (ATG)), the
bacterial cells would be incapable of restarting translation. Additionally,
restriction endonucleases, BamHI and NdeI, were introduced into the forward
primer. HindIII, also a restriction endonuclease, was introduced in the reverse
primer as well. To summarize, the purpose of the introduced restriction
enzyme sites was to provide sites where N- or C-terminal modifications of the
rhodopsin sequence could be inserted.

2.4 TOPO® Cloning Reaction
With the presence of the cloning vehicle (pBAD TOPO® vector) and
PCR product from the prospective gene to be cloned (cDNA encoding bovine
rhodopsin), the cloning process was executed.
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1. In sequential order: 1 microliter (µl) of the PCR product containing the
cDNA of the bovine rhodopsin protein, 1 µl of salt solution
(concentration of 1.2 M NaCl and 0.06 M MgCl2), 3 µl of sterile
water, and 1 µl of the pBAD TOPO® vector (for a final volume of 6
µl) were added to a sterile 1.5 milliliter (ml) test tube. The reagents
were mixed gently and allowed to rest undisturbed at room
temperature (21-23 ˚C) for a total incubation time of 5 minutes. The
(A) overhangs within the PCR product easily allowed its ligation to the
(T) overhangs in the pBAD TOPO® vector, constituting the complete
insertion of the PCR product into the plasmid.
2. The cloning reaction (from the previous step) was placed on crushed
ice after 5 minutes. Once chilled, 1 µl of the cloning reaction was
added to a microcentrifuge tube containing 50 µl of thawed (on ice),
competent cells E.coli cells strain XL-1 blue (Stratagene). Competent
cells are especially efficient at DNA re-uptake. It is believed that
MgCl2 (or another salt) causes the DNA to precipitate and adhere to
the outside of the E.coli cell walls. When the E.coli cells are chilled
and immersed in cold salt-solution, they are more proficient in DNA
uptake than untreated cells. However, the DNA does not enter the
treated cells, but instead, remains attached to the exterior of the cell
walls. Only when the chilled cells are shocked or quickly heated to
42˚C does the DNA enter the competent cells (Brown, 1990).
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3. The tube of competent E.coli cells were placed in a hot water bath
(stabilized to 42˚C) and heat-shocked for 30 seconds. Immediately,
the vial of cells were transferred to ice and incubated between 10-15
minutes.
4. 250 µl of room temperature SOC medium (containing 2% tryptone,
0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM
MgSO4, and 20 mM glucose) was added to the competent cells.
5. The vial of cells was incubated at 37˚C for 1 hour in a non-shaking
incubator.
6. 100 µl of the cells were added and evenly spread on a room
temperature LB-ampicillin plates and incubated (in a non-shaking
incubator) at 37˚C overnight.

2.5 Selection and growth of colonies
A single colony resulted from the TOPO® Cloning reaction. This was
inoculated in a capped, sterile 10 ml test tube containing 2 ml of sterile LB
media (per liter: 10g tryptone, 5g yeast extract, 10g NaCl, and distilled H2O,
adjusted to a pH of 7.0 using NaOH) and 2 µl of filter-sterilized ampicillin (50
mg/ml). The tube was incubated for 16 hours at 37˚C in a non-shaking
incubator.
The following day, 1 ml of the cells and 40 µl of ampicillin (50
mg/ml) were added to a 125 ml flask of 40 ml of sterile LB media and grown
in a shaker bath overnight at 37˚C.
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2.6 DNA Purification of the cloned cells
Plasmid DNA from the cloned cells was purified using Wizard® Plus
SV Minipreps DNA Purification System.
Harvesting of Cells
1. 1.5 ml (from the 40 ml of cells) was added to a sterile 1.5 ml
microcentrifuge tube and centrifuged at 10,000 rpm for 5 minutes.
2. The supernatant was decanted and excess liquid was removed by
inverting the tube and gently blotting it on a kimwipe.
Purification
1. 250 µl of Cell Resuspension solution (50 mM Tris-HCl at pH 7.5, 10
mM EDTA, and 100 µg/ml RNase A) was added to the pelleted cells.
By gently pipetting the solution, the pellet was thoroughly
resuspended.
2. 250 µl of Cell Lysis solution (0.2 M NaOH, 1% SDS) was added to
the tube of cells. Cell lysis solution lyses open the cells allowing the
DNA (and inside contents) to enter solution. The tube was inverted 4
times and incubated at room temperature until the lysate cleared. (The
solution takes on a slimy, viscous consistency).
3. Although not a crucial step, 10 µl of Alkaline Protease solution was
added to the tube and inverted 4 times. The sole purpose of the
protease solution is to deactivate endonucleases and other degrading
enzymes released into the solution during cell lysis. These proteins
may degrade the quality of DNA by nicking portions.
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4. 350 µl of Neutralization solution (4.09M guanidine hydrochloride,
0.759M potassium acetate, and 2.12M glacial acetic acid at a pH of
4.2) was added to the test tube. Sufficient mixing of the contents was
done by inverting the tube 4 times. The acidity of the Neutralization
solution restabilizes the pH to neutral, as too basic a pH damages DNA
by denaturation.
5. The test tube was centrifuged at 10,000 rpm for 10 minutes at room
temperature5 to separate the soluble products (DNA) from the solid
bacterial matter.
Centrifuging the lysate
1. Approximately 850 µl of the cleared lysate was extracted from the
white precipitate (carefully avoiding the transfer of the precipitate) and
transferred to a spin column (already inserted in the 2 ml collection
tube).
2. The spin column and its contents were centrifuged at 10,000 rpm for 1
minute and the flow-through was discarded. At this point, the DNA
binds to the spin column, and all the soluble, excess materials (e.g.,
junk DNA and soluble proteins) are removed in the filtrate.
3. 750 µl of Column Wash solution6 (previously diluted with 35 ml of
95% ethanol) was added to the spin column and centrifuged at 10,000
rpm for 1 minute. The flow-through was subsequently discarded.
Ethanol precipitates the DNA, which continues to adhere to the spin
5

The entire DNA purification process was carried out at room temperature.
The Column wash solution contains 60% ethanol, 60 mM potassium acetate, 8.3 mM TrisHCl, 0.04 mM EDTA).

5
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column. Any trace amounts of residual proteins are removed in the
flow-through.
4. 250 µl of Column wash solution was added to the spin column and
centrifuged for 2 minutes.
5. The spin column was removed, blotted with a Kimwipe to remove
excess column wash solution and transferred to a sterile 1.5 ml
microcentrifuge tube.
6. 60 µl of Nuclease free water was added to the spin column. The tube
was centrifuged for 1 minute at 10,000 rpm for 1 minute and stored in
the freezer at -20˚C. Water resolubilizes the DNA, permitting easy
passage through the spin column.

2.7 Analysis of the Plasmid DNA
The orientation of the bovine rhodopsin gene within the pBAD TOPO
plasmid was analyzed by restriction endonuclease (restriction enzyme)
treatment and agarose gel electrophoresis. By performing enzymatic digests
on the DNA sample, the generation of DNA fragments of varying sizes
directly resulted from the location of the restriction enzyme sites in the DNA
sample. An agarose gel aided in the process of separating the DNA fragments
and created a visual depiction of the gene’s orientation.
Restriction endonuclease digests
The purified plasmid DNA was treated with restriction endonucleases,
NcoI, BamHI, and HindIII. Single digests and double digests were
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performed. For the single digests: 5 µl of the DNA sample, 1 µl of 10x
Buffer, and 1 µl of the restriction endonuclease (totaling 7 µl) were added to a
sterile 0.6 ml microcentrifuge tube. For the double digests: 5 µl of the DNA
sample, 2 µl of 10x buffer, and a total of 2 µl of restriction endonucleases
(totaling 9 µl) were added to a 0.6 ml microcentrifuge tubes. Three double
digests were made in the following combinations: NcoI and HindIII, NcoI and
BamHI, and BamHI and HindIII. All samples were incubated in a nonshaking incubator for 1 hour at 37˚C.
Gel preparation
A 0.8% agarose gel was made using 0.4g of agarose7 10 ml of 5x TBE
buffer (made from 2.7g Tris base, 1.38g boric acid, and 1 ml EDTA in 50 ml
of distilled H2O), and 40 ml of distilled H2O. The ingredients were added to a
125 ml flask and heated until the agarose dissolved. When the solution
roughly cooled to 40˚C, 3 drops of ethidium bromide stock solution (0.5 g/ml)
was added. The solution was poured in a gel-casting mold and allowed to
solidify. After solidification, the gel was loaded in a horizontal gel box and
200 ml of diluted 5x TBE solution (40 ml of buffer in 160 ml of distilled H2O)
to which 3 drops of ethidium bromide were added.
Running samples on the Gel
1. 2 µl of gel loading buffer (with tracking dye) were added to each of
the 3 single digests and 3 double digests.

7

The agarose was made by Fisher BioReagents and has a high melting temperature suitable
for separation of large DNA molecules.
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2. 5 µl of a DNA ladder8 (Gene choice molecular weight standards), 9 µl
of each of the single digests and 10 µl of each of the double digests
were added to the wells of the gel.
3. The gel ran between 30 and 45 minutes in duration at 150 volts.
4. A UV-trans-illuminator/camera Gel Doc (Kodak) provided an image
of the gel, making analysis possible.

2.8 Transformation
After determining the orientation of the bovine rhodopsin gene within
the pBAD TOPO plasmid, E.coli cells from strain UT5600 were transformed.
As an advantageous method, transformation promotes the acquisition and
integration of extrachromosomal DNA into a bacterial cell’s chromosome.
While many bacterial strains are adept in DNA uptake from their
environments, transformation is not entirely efficient primarily because of
DNA degradation9. Easy distinction between cells with successful
transformation and those lacking the plasmid DNA involves the expression of
specific genes by the plasmid DNA. The presence of an ampicillin resistance
gene within the plasmid markedly distinguishes the transformed cells from the
non-transformed cells. Antibiotic resistant genes are transferred to the host
cell in cloning reactions. Cells that lack the ampicillin-resistant gene are
unable to grow on agar plates containing ampicillin (Brown, 1990).

8

The DNA ladder determines the size of DNA molecules ranging from 200 to 12,000 base
pairs in length. 5 µl of the ladder contains 1% agarose in 1x TAE buffer stained with
ethidium bromide.
9
Uptaken DNA often experiences degradation by the host cell.
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Procedure
Transformation of E.coli cells from strain UT5600 was completed
using 1 µl, 2 µl, and 5 µl of the purified recombinant plasmid DNA (pBAD
TOPO + bovine rhodopsin).
1. Three, 1.5 ml microcentrifuge tubes containing 50 ml aliquots of the
E.coli cells (stored -70˚C) were thawed in crushed ice.
2. 1 µl, 2 µl, and 5 µl of the purified plasmid DNA were added to the
tubes. The contents of the tubes were mixed with gentle stirring of the
pipette tip.
3. The tubes were incubated on ice for 5 minutes.
4. Cells were heat shocked at 42˚C in a water bath for 45 seconds.
5. Immediately after heat shocking, the tubes were placed on ice.
6. 200 µl of sterile LB media without ampicillin was added to each of the
3 tubes.
7. The tubes were incubated in a non-shaking incubator at 37 ˚C for 1
hour.
8. 100 µl of cells were taken from each of the 3 tubes and evenly spread
onto LB plates containing ampicillin and incubated at 37 ˚C for 24
hours.

2.9 Protein Expression
Protein expression occurs in two stages, with the first being
transcription and the second, translation. A brief examination of transcription
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(with particular emphasis on initiation) sufficiently details the ability of the
pBAD TOPO plasmid to express the bovine rhodopsin protein.
Transcription10 is the process whereby an RNA transcript is synthesized from
a DNA template. Two important sub-phases within transcription are initiation
and elongation.
1. In the initiation phase (most crucial phase), RNA polymerase must
detect and bind to the promoter11 in order to initiate transcription. The
promoter ultimately controls the expression of a gene. For the bovine
rhodopsin protein to be expressed, RNA polymerase must first bind to
the pBAD promoter (which will subsequently be discussed).
2. In the elongation phase, RNA polymerase reads the template DNA
strand in the 5’ to 3’ direction while simultaneously adding the
complementary RNA bases12. RNA polymerase produces an RNA
transcript complementary to the DNA strand encoding the bovine
rhodopsin gene. The RNA transcript is later translated into the bovine
rhodopsin protein (Chawla, 2000).
Promoter control of protein expression
The pBAD (araBAD) promoter permits the expression of the bovine
rhodopsin protein. Within the pBAD TOPO plasmid, the araC gene lies
adjacent to the pBAD promoter (Wilcox et al., 1974) and positively and
negatively regulates the pBAD promoter (Carra and Schleif, 1993; Lobell and
10

Transcription, one of two steps (the other being translation) in protein synthesis, is
catalyzed by RNA polymerase.
11
A promoter is a short DNA sequence located immediately upstream of the gene to be
transcribed.
12
The four RNA bases are uracil (U), guanine (G), cytosine (C), and adenine (A).
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Schleif, 1990). The presence of arabinose turns on transcription from the
pBAD promoter. Conversely, the opposite is true in the absence of Larabinose, as the pBAD promoter is suppressed by the araC gene resulting in
minimal transcription levels (Lee, 1980; Lee et al., 1987). To summarize, the
pBAD promoter, incorporated in the pBAD TOPO plasmid, functions to
regulate heterologous gene expression of bovine rhodopsin in the E. coli cells
(Guzman et al., 1995).
Procedure
1. A colony was selected from a transformation plate13 and inoculated
into 2 ml of LB media and 2 µl of ampicillin (50 mg/ml) at 37 ˚C in a
non-shaking incubator for 16 hours.
2. The 2 ml overnight culture was added to a sterile 1 L flask containing
350 ml of fresh, enriched LB media (per liter: 10g tryptone, 5g NaCl,
5g yeast extract, 5g NaHPO4 (anhydrous) and 0.5% glycerol adjusted
to pH 7.0) and 350 µl of ampicillin. As the cells grow and consume
glycerol in the LB media, they produce wastes that decrease the pH of
the solution. Fortunately, the phosphate buffer (HPO42-/ H2PO4-)
prevents a drastic lowering of pH that would otherwise occur.
3. The flask was shaken at 200 rpm at 37˚C and the optical density of the
culture was taken every 45 minutes to monitor cell growth.

13

The plate was from the transformation reaction conducted with 5 µl of the purified plasmid
DNA and E. coli cells strain UT5600.
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After 4.5 hours, 3.5 ml of a 20% arabinose solution (made from 2g of Larabinose in 10 ml of distilled water) and approximately 2-5 µl of retinal
stock solution (~50 µM) was added to the cells.
4. The heat of the shaker bath was turned off14 and the cells were allowed
to grow overnight at room temperature.
5. The color of the cells was noted the following day.
Cell lysis
1. The 350 ml culture of cells was equally divided into 175 ml aliquots
and added to two 400 ml centrifuge tubes.
2. The cells were centrifuged at 4,000 rpm for 30 minutes at 4˚C.
3. The supernatant was removed and 5 ml of cell lysis solution (in 20
ml: 10 mM HEPES at pH 7.1, 1 mM PMSF protease inhibitor, 3%
octyl glucoside, 0.08% lysozyme, and 0.01 mg/ml DNAse) was
added to one of the centrifuge tubes (the other was stored at -20˚C).
4. On ice, the cells were thoroughly resuspended with continuous gentle
stirring and the lysate was transferred to a sterile, capped 50 ml
centrifuge tube.
5. The tube was incubated at 4˚C for approximately 70 hours.
6. The lysate was centrifuged at 4,000 rpm for 20 minutes at 4˚C. The
supernatant was removed and used for spectral analysis.

14

Turning off the heat allows a gradual cooling of cells; otherwise overgrowth and minimal
protein expression would occur.
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Chapter 3
Results and Conclusions

3.1 Cloning Reaction
With the appearance of a single colony, the probability of selecting a
colony possessing the correct orientation15 of the bovine rhodopsin gene was
only a 50% chance. As luck would have it, it was not necessary to repeat the
cloning steps to obtain additional colonies,
since the correct orientation was obtained.

Figure-3.1 Culture of cells from the only resulting
colony of the cloning reaction.

3.2 Restriction Enzyme Digests
A restriction enzyme digest was performed on the purified plasmid
DNA containing the bovine rhodopsin gene in order to assess the orientation
of the gene. Restriction endonucleases recognize and cleave DNA at specific
sequences. NcoI recognizes the DNA sequence, 5’ C/CATGG 3’ and cleaves
15

It was possible for the bovine rhodopsin gene to be inserted into the pBAD TOPO plasmid
in either the forward or reverse direction. The correct orientation, and thus highly desired, is
the forward direction.
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between the two cytosines (C). BamHI recognizes the 5’ G/GATCC 3’
sequence and cleaves between the two guanidines (G). HindIII recognizes the
sequence, 5’ A/AGCTT 3’ and cleaves between the two adenosines (A).
Depending on the location of the location of the restriction enzyme sites in a
DNA sequence, performing a digest on a DNA sample will generate
fragments of varying sizes, indicating the direction or size of your DNA
product.
The purified plasmid recombinant DNA is approximately 5.2K base
pairs. As shown in Fig 3.2, capital letters represent the nucleotides sequence
in the pBAD TOPO plasmid and lower case letters represent the bovine
rhodopsin gene (id: NM_00104890). Highlighted in green, red, and blue are
the restriction enzyme sites of BamHI, NcoI, and HindIII respectively.
NcoI has two sites in the recombinant plasmid DNA. The first is 342
base pairs from the first nucleotide and the second is 498 base pairs from the
first nucleotide. Counting from the bottom, the first NcoI site is 4,696 base
pairs from the last nucleotide and the second site is 4,582 base pairs from the
last. BamHI also has two three in the recombinant plasmid DNA. The first
site is 237 base pairs from the first nucleotide, the second is 353 base pairs
from the first nucleotide, and the third site begins at 390 base pairs from the
first nucleotide. Beginning at the bottom, the first site is approximately 4,957
base pairs from the last nucleotide, the second site is 4,841, and the third is
4,804 base pairs from the last nucleotide. Hind 3 has only one site in the
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recombinant plasmid DNA. It is 1,451 nucleotides from the first nucleotide
and 3,743 base pairs from the last nucleotide.

Figure-3.2 Sequence of the pBAD TOPO plasmid (obtained from the Invitrogen website)
with the inserted bovine rhodopsin gene. The DNA molecule is 5,202 base pairs in length and
highlighted in blue, green, red, and blue are the restriction enzyme sites.
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Figure-3.3 Restriction enzyme digest performed on the purified plasmid DNA sample.

Single and double digests were performed on the purified plasmid
DNA containing the bovine rhodopsin gene was treated with restriction
enzymes. It is possible that the position of the cut sites have shifted and this
may be to supercoiled DNA.
The first lane from the left is the DNA ladder. The second lane shows
purified DNA from the pBAD TOPO with the added bovine rhodopsin gene.
The uncut, supercoiled plasmid in lane 2 matches with the 4,000 base pair
(bp) fragment, but is actually expected to have a total length of 5,000 bp. The
third lane shows the Nco1 cut sites with 2 two bands in very close proximity
between the 6,000 and 5,000 bp fragments. The fourth lane shows the BamHI

33
cut sites with the first band from the appearing between the 8,000 and 7,000
bp fragments and the second appearing between the 6,000 and 5,000 bp
fragments. The fifth lane shows HindIII which only has one cut site, giving a
clean band around the 5,000 base pair fragment. In lane 6, the Nco1 sites
(around 4,500 bp on the gel) and the HindIII (around 1,200 bp on gel) are in
close proximity to their correct positions and should be far apart from one
another. In lane 7, appears to have one band, but the NcoI and BamHI sites
are positioned close to one another in the actual DNA sequence. In lane 8, the
BamH1 and the HindIII cut sites are in the correct places at 5,000 bp and
around 1,400 base pairs respectively. If the bovine rhodopsin gene was
inserted in the incorrect direction, a strong 1,400 bp fragment should have
been visible in lanes 3, 4, and 7. Moreover, the agarose gel displaying the
digested DNA sample indicates the correct insertion of the bovine rhodopsin
plasmid.

3.3 DNA Sequence
The purified plasmid DNA (concentration of 129 nanograms per
microliter) and the pBAD forward sequencing primer (concentration of 0.1
µg/µl in TE Buffer) was diluted to the required 1 pM/µl and sent to the SUNY
DNA Sequencing Core Facility for sequencing. In Figure-3.4, generated by
BioEdit version 7.0, the adenines are labeled in green font, cytosines are
labeled in blue font, guanidines are labeled in black font, and thymidines are
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labeled in red font. In addition, nucleotides labeled ‘N’, are of unknown
identity and can be one of the four DNA bases.

Figure-3.4 Fluorescent DNA sequence of the purified plasmid DNA was obtained from the
SUNY DNA Sequencing Core Facility at SUNY Upstate Medical University and generated
by the BioEdit (version 7) program.

Additionally, the DNA sequence obtained from the SUNY Sequencing
Core Facility demonstrates the correct orientation of the bovine rhodopsin

35
gene within the pBAD TOPO plasmid. Had the gene been inserted in the
reverse direction, the generated DNA sequence (from sequencing) would have
been the complement of the DNA sequence shown in Figure-3.5.

Figure-3.5 DNA sequence of the bovine rhodopsin gene obtained from the purified plasmid
DNA sequenced at the SUNY DNA Sequencing Core Facility.

The obtained DNA sequence was compared to the nucleotide sequence
records on the National Center for Biotechnology Information (NCBI) website
using the Basic Local Alignment Search Tool (BLAST) program (Altschul et
al., 1990) and Figure-3.6 shows the results. The purified plasmid DNA
sequence generated a 96% match with NM_001014890, Bos taurus rhodopsin,
due to gaps or mismatched bases, shown in Figure-3.6. All of the errors were
after the 531st nucleotide and therefore probably not significant. Most DNA
sequencing facilities can accurately sequence DNA molecules up to 500 bp in
length. DNA fragments larger than 500 bp are usually sequenced with
inconsistencies beyond the 500th base.
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Figure-3.6 Results of query generated by the BLAST program on the NCBI website.
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3.4 Transformation
After determining the correction orientation of the bovine rhodopsin
gene in the pBAD TOPO plasmid, the purified DNA (from the DNA
purification step) was used to transform E.coli cells strain UT5600, and the
resulting colonies were expected to contain the recombinant DNA molecule.
The presence of an ampicillin resistant gene within the pBAD TOPO plasmid
assured the transfer of ampicillin resistance to the E.coli cells by uptake of the
recombinant DNA molecule. Consequently, only the E.coli cells with the
recombinant DNA molecule could survive on the LB/ampicillin plates.

Figure-3.7 Colonies from the transformation reaction with the recombinant DNA molecule
and E.coli cells strain UT5600.

3.5 Protein Expression
As stated previously, when retinal is added to rhodopsin a red to
purple color is emitted. Regrettably, the cells were not the anticipated red
color; instead, they were an orange-brown color as shown in Figure-3.8. The
lysate exhibited an orange-brown in color instead of the expected red, which
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we believed to be metarhodopsin III, a semi-stable intermediate formed by the
linkage between all-trans retinal and the opsin apoprotein (Bauman, 1972;
Blazynski and Ostroy, 1984; Chabre and Breton, 1979; Ebrey, 1968).

Figure-3.8 E.coli cells lysed with the cell lysis solution. The resulting supernatant was an
orange-brown color.

The metarhodopsin III intermediate absorbs light in the 470 nm region,
and to test for the presence of metarhodopsin III in the lysate, a spectrum was
taken between 190 and 700 nm to confirm its presence. The spectral results
are shown in Figure-3.9. Although no defined spectral peak at 470 nm was
observed, there is broad absorbance throughout the region above 400 nm. We
believe this could be due to the presence of a mixture of different photostates
and/or of partially folded states of rhodopsin in our sample.
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Figure-3.9 Spectra taken on the lysate

3.6 Conclusions
The bovine rhodopsin gene has been successfully cloned into E. coli
cells strain UT5600. Evidence garnered from the restriction enzyme digest,
sequence of the purified DNA sample, BLAST results, and the successful
transformation of the E. coli cells supports this conclusion. However, the
ability of the cells to express the bovine rhodopsin protein in a native or nearnative form is inconclusive and needs further investigation.
Future work on this experiment surrounds refinement of the protein
purification process and possible attainment of crystals from the purified
bovine rhodopsin protein. We want to modify the rhodopsin gene to include
parts of the proteorhodopsin gene that permit citrate induced precipitation.
Ultimately, we want to crystallize the structure of bovine rhodopsin expressed
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in the bacteria in order to compare it to known crystal structures of the bovine
rhodopsin protein derived from cow eyes.
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Capstone Summary

G-protein coupled receptors (GPCRs) make up a total of ~950 genes in
the human genome (Fredriksson and Schioth, 2005; Mirzadegan et al., 2003;
Takeda et al., 2002). GPCRs are important because they play a vital role in
cell signaling in that they relay extracellular messages to a cell’s interior; they
detect and mediate hormones (Heideman and Bourne, 1990); and they are
involved in electron transfer and ion transport, (Trabanino et al., 2004) critical
functions for nerve impulses and other biochemical processes.
Additionally, properly functioning GPCRs are imperative for normal
body function. Minor mutations in GPCR structures result in diseases such as
diabetes and hypertension, dwarfism, obesity, and retinitis pigmentosa
(Wilson, et al., 1998). Other manifested conditions resulting from deficient
GPCRs include: allergies, anxiety, asthma, congestive heart failure, migraines,
Parkinson’s, and ulcers (Wilson and Bergsma, 2000). As you can imagine, a
malfunctioned GPCR is potentially deadly.
However, much of what is currently known about GPCR structure was
based on X-ray crystallographic measurements of rhodopsin. This was the
only GPCR with a known structure until the recent determination of the
crystal structure of the human ß2 adrenergic G-protein coupled receptor
(Rasmussen et al., 2007). Of the presently available therapeutic drugs,
approximately 40% of them target GPCRs (Muller, 2000; Sautel et al., 2000).
The goal of finding new pharmaceuticals would be aided if the identity and
structures of more GPCRS were known.
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Rhodopsin, the source of investigation in our experiment, has been
extensively studied because it is readily available and accessible for
manipulation, plays an important role in vision, and its active and inactive
states are easily quantified (Ebrey and Koutalos, 2001; Hargrave, 2001; Okada
et al., 2001; Okada and Palczewski, 2001; Filipek et al., 2003(b)).

Further,

earliest crystallized structures of rhodopsin have provided information its
helical arrangements and interactions, chromophore binding site, and
extracellular ligand binding interactions in other types of GPCRs (Palczewski
et al., 2000).
In the current experiment, the gene for bovine rhodopsin protein, a
mammalian gene, was cloned into Escherichia coli (E.coli) cells strain
UT5600. The main goal was to assess the capability of a GPCR to be
expressed in large quantities as a functional protein in bacterial cells.
Successful expression of bovine rhodopsin in E.coli could pave the way for
cheaper and less complex of GPCR proteins suitable for crystallization trials.
The pBAD TOPO TA Expression kit purchased from Invitrogen was
used to conduct the cloning process. PCR (Polymerase chain reaction) was
used to amplify the prospective gene to be cloned, cDNA of bovine rhodopsin.
The gene, in the form of bovine rhodopsin cDNA, was contributed by Jeremy
Nathans, et al. (1989).
Cloning is the process whereby a gene is manipulated and inserted into
an organism in which it is not naturally found (Brown, 1990). In the TOPO®
Cloning reaction, the bovine rhodopsin gene was inserted into the pBAD
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TOPO plasmid to form a recombinant DNA molecule. The recombinant DNA
molecule, when uptaken by the E. coli cells strain XL-1 blue, made copies of
itself along with the bovine rhodopsin gene. As a single E. coli cell divided,
copies of the recombinant DNA molecule were passed on to its progeny. The
E. coli cell continued to divide until it formed a colony, or cluster of cells.
A single colony resulted from the TOPO® Cloning reaction and was
subsequently grown in a 40 ml flask containing LB media (food for the
bacteria). One and a half milliliters were taken from the culture and DNA was
extracted from the cells and purified using a Wizard® Plus SV Minipreps
DNA Purification System.
The purified plasmid DNA containing the cloned PCR product was
treated with restriction enzymes and then analyzed on a 0.8% agarose gel to
determine the correct orientation of the bovine rhodopsin gene. Restriction
enzymes cut DNA at specific sequences. So treating the DNA sample with
restriction enzymes produced DNA fragments of varying sizes based on the
location of the restriction enzyme sites in the DNA sample. The agarose gel
aided in the process of separating the DNA fragments and created a visual
depiction of the gene’s orientation. Based on the results of the gel, we
determined the bovine rhodopsin gene to be inserted in the correct direction in
the pBAD TOPO plasmid. Furthermore, the DNA was sequenced and
compared to the nucleotide sequence records on the National Center for
Biotechnology Information (NCBI) website using the Basic Local Alignment
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Search Tool (BLAST) program (Altschul et al., 1990) and was determined to
have the correct orientation.
The purified plasmid DNA was used to transform E. coli cells strain
UT5600, and the resulting colonies were grown in growth media containing
ampicillin. To induce expression of rhodopsin, the sugar L-arabinose was
added to the cells along with retinal (which causes the opsin protein to turn a
red color).
The entire culture was centrifuged and the supernatant was removed.
Cell lysis solution was added to the cells to extract the protein. The lysate
exhibited an orange-brown color, which we believed to be the result of alltrans retinal (present as one of many isomers in the retinal stock solution that
was added to the cells) combining with the opsin apoprotein (part of the
rhodopsin protein) to form an intermediate called metarhodopsin III (Heck et
al., 2003).
In summary, the bovine rhodopsin gene was successfully cloned into
the bacterial cells, although the expressed protein was not completely refolded
to the native rhodopsin form. The sequenced DNA obtained from the SUNY
DNA Sequencing Core Facility, BLAST query results, and restriction enzyme
digests proves that the bovine rhodopsin gene was not only inserted into the
E.coli cells but inserted with the correct orientation. Also, the ability of the
cells to express the bovine rhodopsin protein is inconclusive and needs further
investigation. Future work on this experiment surrounds refinement of the
protein purification process and possible attainment of crystals from the
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purified bovine rhodopsin protein. We want to crystallize the structure of
bovine rhodopsin expressed in the bacteria in order to compare it to known
crystal structures of the bovine rhodopsin protein derived from cow eyes.

